Side-by-side comparison of AI visibility scores, market position, and capabilities
Bengaluru YC W23 AI UPSC exam coaching for 60K+ students in India's most competitive civil services exam; $2.53M YC/FundersClub/GoodWater seed May 2024 with personalized AI mentor competing with Unacademy and PW for UPSC preparation.
SuperKalam is a Bengaluru, India-based AI-powered test preparation platform — backed by Y Combinator (W23) with $2.53 million in total funding including a $2 million seed in May 2024 led by Y Combinator and FundersClub with participation from Puneet Kumar, GoodWater Capital, Nurture Ventures, SuperCapital, and Pareto Ventures — providing 60,000+ Indian students with AI-powered mentorship and personalized study guidance for the UPSC Civil Services Examination, India's most competitive government job exam that receives 500,000-900,000 applications annually for approximately 1,000 positions. Founded in 2023 by Vimal Singh Rathore and Aseem Gupta (IIT Madras alumni), SuperKalam targets the UPSC aspirant market where preparation typically requires 1-3 years of intensive study and coaching costs ₹50,000-₹200,000 per year.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.